- Release Date: 05/09/13 17:34
- Summary: RELINT: FPH: Disclosure of Director and Officer Relevant Interests
- Price Sensitive: No
- Download Document 8.33KB
FPH 05/09/2013 15:34 RELINT REL: 1534 HRS Fisher & Paykel Healthcare Corporation Limited RELINT: FPH: Disclosure of Director and Officer Relevant Interests Name of director or officer of public issuer: Deborah Anne BAILEY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Human Resources B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: Ordinary shares and options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Deborah Anne BAILEY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 3 September 2013 Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation: 3 September 2013 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acqusition or disposal took place: Cancellation of 23,333 FPH options and issue of 1,092 ordinary shares E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 18 December 2012 Name of director or officer of public issuer: Lewis George GRADON Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Research & Development B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: Ordinary shares and options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Lewis George GRADON D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 3 September 2013 Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation: 3 September 2013 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acqusition or disposal took place: Cancellation of 46,667 FPH options and issue of 2,184 ordinary shares E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 18 December 2012 Paul Nigel SHEARER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Sales & Marketing B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: Ordinary shares and options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Paul Nigel SHEARER D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 3 September 2013 Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation: 3 September 2013 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acqusition or disposal took place: Cancellation of 46,667 FPH options and issue of 2,184 ordinary shares E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 18 December 2012 Name of director or officer of public issuer: Antony George BARCLAY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chief Financial Officer & Company Secretary B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: "i) Ordinary shares and options to acquire ordinary shares ii) Ordinary shares and options to acquire ordinary shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Antony George BARCLAY D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: "i) 30 August 2013 ii) 3 September 2013" Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation: i) 30 August 2013; ii) 3 September 2013 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: "i) Cancellation of 16,667 FPH options and issue of 372 ordinary shares; ii) Cancellation of 16,666 FPH options and issue of 780 ordinary shares; " E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 12 July 2013 Name of director or officer of public issuer: Winston FONG Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President ICT B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: "i) Ordinary shares and options to acquire ordinary shares; ii) Ordinary shares and options to acquire ordinary shares" C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Winston FONG D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition: 3 September 2013 Consideration paid for acquisition: $Nil If the relevant interest was disposed of-- Date of cancellation: 3 September 2013 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acquisition or disposal took place: "i) Cancellation of 15,000 FPH options and issue of 702 ordinary shares; ii) Cancellation of 23,333 FPH options and issue of 2,818 ordinary shares" E Total number of transactions this notice relates to: Two F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 12 July 2013 Name of director or officer of public issuer: Michael Grenfell DANIELL Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Managing Director/Chief Executive Officer B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: Ordinary shares and options to acquire ordinary shares C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: Beneficial Ownership Name of registered holder of securities Michael Grenfell DANIELL D Details of acquisitions and disposals If the relevant interest was acquired-- Date of acquisition 3 September 2013 Consideration paid for acquisition $Nil If the relevant interest was disposed of-- Date of cancellation: 3 September 2013 Consideration received for cancellation: $Nil Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the acqusition or disposal took place: Cancellation of 53,333 FPH options and issue of 2,497 ordinary shares E Total number of transactions this notice relates to: One F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 12 July 2013 End CA:00240755 For:FPH Type:RELINT Time:2013-09-05 15:34:48
Ann: RELINT: FPH: Disclosure of Director and Offi
Add to My Watchlist
What is My Watchlist?
